If You Want to Keep Your Memory Sharp and Your Brain Healthy, Researchers Say You Should Start Doing This Now - Yahoo Lifestyle Canada

New global surveillance data reveal dramatic increases in reported bluetongue and West Nile fever events, raising concerns about climate change, expanding disease territories, and the future of animal health. The world's disease map is changing, and veterinarians are being urged to pay attention. From biting midges carrying bluetongue virus across Europe to mosquitoes spreading West Nile fever, vector-borne diseases are emerging in new regions, creating growing challenges for animal health professionals, livestock producers, and public health officials. The World Organisation for Animal Health (WOAH) issued a warning on October 9, 2026, calling for stronger disease surveillance, earlier detection, and better international cooperation as reports of several vector-borne diseases continue to climb. An analysis of information submitted through the World Animal Health Information System (WAHIS) reveals a particularly striking increase in reported exceptional epidemiological events since 2023. The findings suggest that shifting environmental conditions, changing vector populations, and animal movements are reshaping where certain infectious diseases can spread.

Continuous glucose monitors (CGMs) could transform diabetes management for millions of Americans with type 2 diabetes who don't take insulin, according to findings published in the New England Journal of Medicine. The clinical trial found that adults using CGMs spent approximately five additional hours each day within their target blood sugar range compared with those receiving routine care. Nearly twice as many CGM users also achieved an A1c level below 7%, a common treatment goal for people with diabetes.

Patients who wore noise-canceling headphones during minimally invasive gynecological surgery were significantly less likely to experience postoperative nausea and vomiting (PONV), suggest findings from a randomized clinical trial presented at the Anesthesiology 2026 annual meeting.

“Beyond Detecting Cancer Recurrence: Can Whole-Genome Sequencing-Based ctDNA Monitoring Help Personalize Adjuvant Treatment? An exciting new study published in The Oncologist highlights the clinical potential of Signatera Genome, a whole-genome sequencing (WGS)-based, tumor-informed circulating tumor DNA (ctDNA) assay, not only for detecting molecular residual disease (MRD), but also for potentially informing adjuvant treatment decisions.